Market Value381,251,000
Total Holdings124
File Date2021-11-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RCAT / Red Cat Holdings, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
INMB / INmune Bio, Inc.
TBPH / Theravance Biopharma, Inc.
SPNV / Supernova Partners Acquisition Company Inc - Class A
US0207511033 / Alpha Healthcare Acquisition Corp., Class A
SRSAU / Sarissa Capital Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
XENT / Intersect ENT Inc
TARS / Tarsus Pharmaceuticals, Inc.
ACEV / ACE Convergence Acquisition Corp - Class A
/ PureCycle Technologies, Inc.
GIWWU / GigInternational1 Inc - Units (1 Ord Share & 1/2 War)
KYG0190X1007 / Ajax I
QELL / Qell Acquisition Corp - Class A
US0207511116 / Alpha Healthcare Acquisition Corp.
IGMS / IGM Biosciences, Inc.
BBIO / BridgeBio Pharma, Inc.
AFMD / Affimed N.V.
YMTX / Yumanity Therapeutics Inc
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
MYGN / Myriad Genetics, Inc.
EYES / Vivani Medical Inc
CLAY / Chavant Capital Acquisition Corp.
IFRX / InflaRx N.V.
VLON / Vallon Pharmaceuticals Inc
FULC / Fulcrum Therapeutics, Inc.
BCTXW / BriaCell Therapeutics Corp. - Equity Warrant
FLUX / Flux Power Holdings, Inc.
CSTL / Castle Biosciences, Inc.
HEPA / Hepion Pharmaceuticals, Inc.
VREX / Varex Imaging Corporation
TWND / Tailwind Acquisition Corp - Class A
HSAQ / Health Sciences Acquisitions Corp 2
LSAQ / LifeSci Acquisition II Corp
PODD / Insulet Corporation
MITAU / Coliseum Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
ALGS / Aligos Therapeutics, Inc.
NTRA / Natera, Inc.
KRBP / Kiromic BioPharma, Inc.
ALNA / Allena Pharmaceuticals Inc
EYPT / EyePoint Pharmaceuticals, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
CELC / Celcuity Inc.
AVDL / Avadel Pharmaceuticals plc
LNTH / Lantheus Holdings, Inc.
CLBR.U / Colombier Acquisition Corp. II - Debt/Equity Composite Units
MORF / Morphic Holding, Inc.
VINC / Vincerx Pharma, Inc.
TVTX / Travere Therapeutics, Inc.
AGLE / Aeglea BioTherapeutics Inc
TMPM / Turmeric Acquisition Corp - Class A
CARA / Cara Therapeutics, Inc.
JYAC / Jiya Acquisition Corp - Class A
CLDX / Celldex Therapeutics, Inc.
BLU / Bellus Health Inc
CRDF / Cardiff Oncology, Inc.
ACET / Adicet Bio, Inc.
MBTC / Nocturne Acquisition Corporation
VRCA / Verrica Pharmaceuticals Inc.
CHAQ / Chardan Healthcare Acquisition 2 Corp
IMTXW / Immatics N.V. - Equity Warrant
EUCR / Eucrates Biomedical Acquisition Corp
HAE / Haemonetics Corporation
PSTX / Poseida Therapeutics, Inc.
IRTC / iRhythm Technologies, Inc.
FMAC / FirstMark Horizon Acquisition Corp - Class A
STIM / Neuronetics, Inc.
ADMS / Adamas Pharmaceuticals Inc
LAAA / Lakeshore Acquisition I Corp
KLR / Kaleyra Inc
SARISSA CAPITAL ACQUISITN CO / *W EXP 10/23/202 (G7823W110)
/ Reservoir Media, Inc.
CHAQ.WS / Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
SNCR / Synchronoss Technologies, Inc.
POL.WS / Polished.com Inc. Warrants to Warrants to Purchase Common Stock
US41150T1161 / WARRANT
/ Hillman Solutions Corp.
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
PRTG / Portage Biotech Inc.
UPH.WS / UpHealth, Inc. Warrants exercisable for one share of at an exercise price of $11.50 pe
ARQT / Arcutis Biotherapeutics, Inc.
HCAQ / HealthCor Catalio Acquisition Corp - Class A
ARYE / ARYA Sciences Acquisition Corp V - Class A
CHAVANT CAPITAL ACQUISITN CO / *W EXP 99/99/999 (G2058L111)
KYG9127T1242 / WARRANTS
PRDS / Pardes Biosciences Inc
GIGINTERNATIONAL1 INC / (37518W106)
US37518W1146 / GigInternational1, Inc.
KYG535211117 / Lakeshore Acquisition I Corp.
SCYX / SCYNEXIS, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SIEN / Sientra, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
IMTX / Immatics N.V.
KALV / KalVista Pharmaceuticals, Inc.
COCP / Cocrystal Pharma, Inc.
CCAC / CITIC Capital Acquisition Corp - Class A
MCRB / Seres Therapeutics, Inc.
LFMD / LifeMD, Inc.
IMCC / IM Cannabis Corp.
CTMX / CytomX Therapeutics, Inc.
ACHV / Achieve Life Sciences, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
CRIS / Curis, Inc.
ECOR / electroCore, Inc.
BTTR / SRx Health Solutions Inc.
CERE / Cerevel Therapeutics Holdings, Inc. Put
ICAD / iCAD, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
SRGA / Surgalign Holdings Inc
ONCT / Oncternal Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
ELOX / Eloxx Pharmaceuticals, Inc.
GMED / Globus Medical, Inc.
INFI / Infinity Pharmaceuticals Inc.
KRYS / Krystal Biotech, Inc. Call
ONCR / Oncorus, Inc.
TCRR / Tcr2 Therapeutics Inc
PRQR / ProQR Therapeutics N.V.
GRTX / Galera Therapeutics, Inc.
IKT / Inhibikase Therapeutics, Inc.
RGNX / REGENXBIO Inc.
ALDX / Aldeyra Therapeutics, Inc.
BLSA / BCLS Acquisition Corp - Class A
SRSA / Sarissa Capital Acquisition Corp - Class A
PROF / Profound Medical Corp.
EPIX / ESSA Pharma Inc.
TCON / TRACON Pharmaceuticals, Inc.
TKNO / Alpha Teknova, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
ILMN / Illumina, Inc.
APLS / Apellis Pharmaceuticals, Inc. Put
MLTX / MoonLake Immunotherapeutics
BCTX.W / BriaCell Therapeutics Corp. - Equity Warrant
CMRX / Chimerix, Inc.
OMEG / Omega Alpha SPAC - Class A
MOTV / Motive Capital Corp - Class A
PHAS / PhaseBio Pharmaceuticals Inc
CDNA / CareDx, Inc
ISEE / IVERIC bio Inc
RNA / Avidity Biosciences, Inc.
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
OCUL / Ocular Therapeutix, Inc.
CLBR / Colombier Acquisition Corp. II
VSTM / Verastem, Inc.
G53521103 / Lakeshore Acquisition I Corp.
KDNY / Chinook Therapeutics Inc
PALI / Palisade Bio, Inc.
VRPX / Virpax Pharmaceuticals, Inc.
MITA / Coliseum Acquisition Corp.
CERS / Cerus Corporation
SNAX / Stryve Foods, Inc.
XFOR / X4 Pharmaceuticals, Inc.
VQS / VIQ Solutions Inc
CLBR.WS / Colombier Acquisition Corp. II - Equity Warrant
IMVT / Immunovant, Inc.
MBTCR / Nocturne Acquisition Corp - Tradeable Rights - May 2021
INSM / Insmed Incorporated
PTGX / Protagonist Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
KRMD / KORU Medical Systems, Inc.
CVRX / CVRx, Inc.
CTIC / CTI BioPharma Corp
NVRO / Nevro Corp.
DDI / DoubleDown Interactive Co., Ltd. - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
INSP / Inspire Medical Systems, Inc.
MEIP / MEI Pharma, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
US30258N1211 / WARRANT
KROS / Keros Therapeutics, Inc.
XTNT / Xtant Medical Holdings, Inc.
XENE / Xenon Pharmaceuticals Inc.
SRZNW / Surrozen, Inc. - Equity Warrant